APPLICATION
ANDA060770
TYPE
ANDA
ORIGINAL APPROVAL
1967-09-29
LATEST ACTION
2025-03-31
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
OXYTETRACYCLINE HYDROCHLORIDEDiscontinued
OXYTETRACYCLINE HYDROCHLORIDE EQ 250MG BASE · CAPSULE · ORAL
Approval history
2025-03-31Labeling · Supplement 4 · standardAP
1991-06-11Manufacturing (CMC) · Supplement 3AP
1990-12-10Labeling · Supplement 2AP
1967-09-29OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.